BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3112442)

  • 1. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
    Sagawa M; Sakuma T; Takahashi S; Usuda K; Satoh M; Kamma K; Ohta S; Nagamoto N; Imai T; Saitoh Y
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2564-7. PubMed ID: 3039922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
    Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
    Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
    Bruntsch U; Groos G; Tigges FJ; Gallmeier WM
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):905-9. PubMed ID: 6540191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microangiopathic hemolytic anemia associated with gastric cancer].
    Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
    Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 11. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
    Gulati SC; Sordillo P; Kempin S; Reich L; Magill GB; Scheiner E; Clarkson B
    Cancer; 1980 May; 45(9):2252-7. PubMed ID: 7379025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin-associated renal failure. Case report and review.
    Hamner RW; Verani R; Weinman EJ
    Arch Intern Med; 1983 Apr; 143(4):803-7. PubMed ID: 6340628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microangiopathic hemolytic anemia associated with mitomycin-C treatment].
    Godes M; Camps C; Martínez A
    An Med Interna; 1991 Dec; 8(12):611-3. PubMed ID: 1782316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent renal microangiography after mitomycin C therapy.
    Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
    Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review.
    Nordström B; Strang P
    Anticancer Res; 1993; 13(5C):1845-9. PubMed ID: 8267391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
    Giroux L; Bettez P; Giroux L
    Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.